Back to Treatments

Treatment

Liposomal Amphotericin B

1
Conditions
18
Trials
5,500
Participants
50%
Average Safety

Condition Evidence

Visceral leishmaniasis

18 trials · 5,500 participants

96% effectiveness · 50% safety
Liposomal Amphotericin B | DFDA